Company Overview and News

Wall Street slips on US-China trade talk uncertainty

6h thehindubusinessline
The Dow Jones Industrial Average fell 178.88 points, or 0.72 per cent, at 24,834.41, the S&P 500 lost 8.57 points, or 0.31 per cent, to 2,724.44 and the Nasdaq Composite dropped 15.58 points, or 0.21 per cent, to 7,378.46.

Aussie car revival: British guru says carmaking to return Down Under in ‘next two or three years’

PRODUCING cheaper, lighter electric cars means Australia can again be a competitive vehicle manufacturer, a leading British industrialist says.

Aussie car industry ‘will live again’

Car manufacturer Holden will recall more than 300,000 vehicles in Australia fitted with defective Takata airbags. About 330,000 vehicles will be recalled, including popular models such as the Astra and Cruze hatchbacks, the company said in a statement on Friday. Photo credit: Facebook/@holdenaustralia

Wall Street slips on US-China trade talk uncertainty; energy falls

8h moneycontrol
US stocks ended lower on Tuesday, weighed down by lingering uncertainty over the outcome of trade talks between the United States and China and declines in energy and industrial shares.

China’s lower car tariffs mean more to BMW than Ford or Tesla

8h scmp
China’s move to reduce tariffs on imported cars to 15 per cent makes little difference to US carmakers.

AutoZone Stock Tanks: Lackluster Third-Quarter Comp Sales

15h marketrealist
The largest US auto parts retailer by store count, AutoZone (AZO), released its fiscal Q3 2018 earnings today before the market opened. The company’s third fiscal quarter covered the 12 weeks that ended on May 5. AZO’s third-quarter adjusted earnings rose 17% year-over-year to $13.42 per share, beating Wall Street’s consensus estimates of $12.97 per share.

Advance Auto Parts’ Sales Fell for the Third Consecutive Quarter

17h marketrealist
Advance Auto Parts (AAP) released its fiscal Q1 2018 earnings today before the market opened, which covered the 16 weeks up to April 21. The company’s first-quarter adjusted earnings grew 32% year-over-year to $2.10 per share, beating analysts’ estimates of $1.97 per share.

Facebook: Currently Undervalued

17h seekingalpha
Facebook's user growth and engagement are important metrics, but not as important as the trajectory of free-cash-flow generation and balance-sheet net cash at this point in its life cycle.

The biggest winner from the unfolding US-China trade deal so far is Germany

17h cnbc
Beijing's latest concession in a trade dispute with the U.S. will likely benefit Germany the most.

Top Ranked Income Stocks to Buy for May 22nd

17h zacks
Here are three stocks with buy rank and strong income characteristics for investors to consider today, May 22nd:

Wall Street edges higher as US-China trade talks progress

18h channelnewsasia
U.S. stock index futures rose on Tuesday on signs of further progress in trade talks between the United States and China as the world's two largest economies pull back from the brink of a full-blown trade war.

WRAPUP 6-Global stocks mixed amid Wall St profit taking, European rally, China moves

18h reuters
* Oil rises to $80 per barrel (Updates with opening of U.S. markets, changes dateline; previous LONDON)

US stocks edge higher as technology companies, banks rise

NEW YORK (AP) — Technology companies and banks are rising Tuesday morning as U.S. stocks head higher for the second day in a row. Automakers are climbing after China said it will reduce auto import duties, another sign the two powers are resolving some of their differences on trade. Chipmaker Micron Technology is surging after it said it will buy back $10 billion in stock.

Wall Street gains as US-China trade talks gather pace

20h channelnewsasia
U.S. stock index futures rose on Tuesday on signs of further progress in trade talks between the United States and China as the world's two largest economies pull back from the brink of a full-blown trade war.

US-China Trade War on Hold: Will General Motors Benefit?

20h marketrealist
Last week, General Motors (GM) stock settled at $37.79 with ~2.4% gains from the previous week’s closing price. In the prior week, the stock remained mixed and rose 0.5%. As of May 18, General Motors stock has risen 4.0% on a quarter-to-date basis. In 2018 so far, the stock was still trading in negative territory, and it was off by 7.8% as compared to the S&P 500 index’s 1.5% gains.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...

CUSIP: 37045V100